Equipe MSITO (Métabolisme des stérols et innovations thérapeutiques en oncologie)


Ferrer L, Kraeber-Bodéré, F, Bodet-Milin C, Rousseau C, Le Gouill S, Wegener WA, Goldenberg DM, Bardiès M (2010). "Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy". Cancer 116, 1093-1100.


Descourt P, Carlier T, Du Y, Song X, Buvat I, Frey EC, Bardiès M, Tsui BMW and Visvikis D (2010). "Implementation of Angular Response Function modeling in SPECT simulations with GATE". Phys Med Biol 55(9), N253.


Lassmann M, Strigari L and Bardiès M (2010). "Dosimetry is Alive and well". Letter to the editor. Cancer Biother Radiopharm 25(5) :593-595.


Boudousq V, Ricaud S, Garambois V, Bascoul-Mollevi C, Boutaleb S, Busson M, Quenet F, Colombo PE, Bardiès M, Kotzki PO, Navarro-Teulon I, Pèlegrin A and Pouget JP (2010). "Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high-activities of non-internalizing 125I-labeled monoclonal antibodies". J Nucl Med 51(11) : 1748-1755.


Laffon E, Bardiès M, Barbet J and Marthan R (2010). Kinetic model analysis for absorbed dose calculation applied to brain in [18F]-FDG PET Imaging. Cancer Biother Radiopharm 25(6) : 665-669.


Hindorf C, Glatting G, Chiesa C, Lindén O, Flux G & EANM Dosimetry Committee (2010). "EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry". Eur J Nucl Med Mol Imaging 37: 1238-1250.



Frampas E, Maurel C, Remaud-Le Saec P, Mauxion T, Faivre-Chauvet A, Davodeau F, Goldenberg D M, Bardiès M and Barbet J (2011) "Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide". Eur J Nucl Med Mol Imaging 38 2153-64


Lassmann M, Chiesa C, Flux, G and Bardiès M (2011). "EANM Dosimetry Committee Guidance Document: Good Practice of Clinical Dosimetry Reporting". Eur J Nucl Med Mol Imaging 38(1): 192-200.


Bardiès M, Buvat I (2011). "What are the specifics in image quantification for dosimetry ? " Q J Nucl Med Mol Imaging 55: 5-20.


Eberlein U, Broer J H, Vandevoorde C, Santos P, Bardiès M, Bacher K, Nosske D and Lassmann M (2011) "Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review". Eur J Nucl Med Mol Imaging 38: 2269-81.


Pouget JP, Navarro-Teulon I, Bardiès M, Chouin N, Cartron G, Pèlegrin A and Azria D (2011) "Clinical radioimmunotherapy—the role of radiobiology". Nat. Rev. Clin. Oncol. 8: 720-34.



Savolainen S, Konijnenberg M, Bardiès M, Lassmann M, Strigari L, Chiesa C, Chiti A, Reijonin V & Flux G (2012) "Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail". Eur J Nucl Med Mol Imaging 39 (DOI 10.1007/s00259-011-2036-1).


Anizan N, Carlier T, Hindorf C, Barbet J and Bardiès M (2012) "setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system". Eur J Nucl Med Mol Imaging Research (In press)